Roles of viral and cellular proteins in the expression of alternatively spliced HTLV-1 pX mRNAs

Virology

Volumn 317, Issue 1, 2003, Pages 136-145

  Princler, Gerald L ^a   Julias, John G ^a   Hughes, Stephen H ^a   Derse, David ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; GENE PRODUCT; MESSENGER RNA; REGULATOR PROTEIN; REX PROTEIN; TAX PROTEIN; VIRUS PROTEIN; VIRUS RNA;

ALTERNATIVE RNA SPLICING; ARTICLE; CELL LINE; CONTROLLED STUDY; DNA FLANKING REGION; EXON; GENETIC CODE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; NONHUMAN; OPEN READING FRAME; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROVIRUS; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE; VIRUS GENE; VIRUS GENOME; VIRUS INFECTION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 0345735917     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2003.09.010     Document Type: Article

References (55)

1. Albrecht B., Collins N.D., Burniston M.T., Nisbet J.W., Ratner L., Green P.L., Lairmore M.D. Human T-lymphotropic virus type 1 open reading frame I p12(I) is required for efficient viral infectivity in primary lymphocytes. J. Virol. 74:(21):2000;9828-9835.
2. Albrecht B., D'Souza C.D., Ding W., Tridandapani S., Coggeshall K.M., Lairmore M.D. Activation of nuclear factor of activated T cells by human T-lymphotropic virus type 1 accessory protein p12(I). J. Virol. 76:(7):2002;3493-3501.
3. Amendt B.A., Hesslein D., Chang L.J., Stoltzfus C.M. Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1. Mol. Cell Biol. 14:(6):1994;3960-3970.
4. Bangham C.R. HTLV-1 infections. J. Clin. Pathol. 53:(8):2000;581-586.
5. Bartoe J.T., Albrecht B., Collins N.D., Robek M.D., Ratner L., Green P.L., Lairmore M.D. Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo. J. Virol. 74:(3):2000;1094-1100.
6. Berneman Z.N., Gartenhaus R.B., Reitz M.S. Jr., Blattner W.A., Manns A., Hanchard B., Ikehara O., Gallo R.C., Klotman M.E. Expression of alternatively spliced human T-lymphotropic virus type I pX mRNA in infected cell lines and in primary uncultured cells from patients with adult T-cell leukemia/lymphoma and healthy carriers. Proc. Natl. Acad. Sci. USA. 89:(7):1992;3005-3009.
7. Bilodeau P.S., Domsic J.K., Mayeda A., Krainer A.R., Stoltzfus C.M. RNA splicing at human immunodeficiency virus type 1 3′ splice site A2 is regulated by binding of hnRNP A/B proteins to an exonic splicing silencer element. J. Virol. 75:(18):2001;8487-8497.
8. Blanchette M., Chabot B. Modulation of exon skipping by high-affinity hnRNP A1-binding sites and by intron elements that repress splice site utilization. EMBO J. 18:(7):1999;1939-1952.
9. Bohl J., Hull B., Vande Pol S.B. Cooperative transformation and coexpression of bovine papillomavirus type 1 E5 and E7 proteins. J. Virol. 75:(1):2001;513-521.
10. Caceres J.F., Stamm S., Helfman D.M., Krainer A.R. Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science. 265:(5179):1994;1706-1709.
11. Caputo A., Haseltine W.A. Reexamination of the coding potential of the HTLV-1 pX region. Virology. 188:(2):1992;618-627.
12. Cereseto A., Berneman Z., Koralnik I., Vaughn J., Franchini G., Klotman M.E. Differential expression of alternatively spliced pX mRNAs in HTLV-I-infected cell lines. Leukemia. 11:(6):1997;866-870.
13. Cho I., Sugimoto M., Mita S., Tokunaga M., Imamura F., Ando M. In vivo proviral burden and viral RNA expression in T cell subsets of patients with human T lymphotropic virus type-1-associated myelopathy/tropical spastic paraparesis. Am. J. Trop. Med. Hyg. 53:(4):1995;412-418.
14. Chung H., Derse D. Binding sites for Rev and ASF/SF2 map to a 55-nucleotide purine-rich exonic element in equine infectious anemia virus RNA. J. Biol. Chem. 276:(22):2001;18960-18967.
15. Ciminale V., Pavlakis G.N., Derse D., Cunningham C.P., Felber B.K. Complex splicing in the human T-cell leukemia virus (HTLV) family of retroviruses novel mRNAs and proteins produced by HTLV type I . J. Virol. 66:(3):1992;1737-1745.
16. Collins N.D., D'Souza C., Albrecht B., Robek M.D., Ratner L., Ding W., Green P.L., Lairmore M.D. Proliferation response to interleukin-2 and Jak/Stat activation of T cells immortalized by human T-cell lymphotropic virus type 1 is independent of open reading frame I expression. J. Virol. 73:(11):1999;9642- 9649.
17. Collins N.D., Newbound G.C., Albrecht B., Beard J.L., Ratner L., Lairmore M.D. Selective ablation of human T-cell lymphotropic virus type 1 p12I reduces viral infectivity in vivo. Blood. 91:(12):1998;4701-4707.
18. Damgaard C.K., Tange T.O., Kjems J. hnRNP A1 controls HIV-1 mRNA splicing through cooperative binding to intron and exon splicing silencers in the context of a conserved secondary structure. RNA. 8:(11):2002;1401-1415.
19. Dekaban G.A., Peters A.A., Mulloy J.C., Johnson J.M., Trovato R., Rivadeneira E., Franchini G. The HTLV-I orfI protein is recognized by serum antibodies from naturally infected humans and experimentally infected rabbits. Virology. 274:(1):2000;86-93.
20. Derse D., Mikovits J., Ruscetti F. X-I and X-II open reading frames of HTLV-I are not required for virus replication or for immortalization of primary T-cells in vitro. Virology. 237:(1):1997;123-128.
21. Ding W., Albrecht B., Kelley R.E., Muthusamy N., Kim S.J., Altschuld R.A., Lairmore M.D. Human T-cell lymphotropic virus type 1 p12(I) expression increases cytoplasmic calcium to enhance the activation of nuclear factor of activated T cells. J. Virol. 76:(20):2002;10374-10382.
22. Ding W., Albrecht B., Luo R., Zhang W., Stanley J.R., Newbound G.C., Lairmore M.D. Endoplasmic reticulum and cis-golgi localization of human T-lymphotropic virus type 1 p12(I) association with calreticulin and calnexin . J. Virol. 75:(16):2001;7672-7682.
23. Franchini G., Mulloy J.C., Koralnik I.J., Lo Monico A., Sparkowski J.J., Andresson T., Goldstein D.J., Schlegel R. The human T-cell leukemia/ lymphotropic virus type I p12I protein cooperates with the E5 oncoprotein of bovine papillomavirus in cell transformation and binds the 16-kilodalton subunit of the vacuolar H+ ATPase. J. Virol. 67:(12):1993;7701-7704.
24. Fu X.D. The superfamily of arginine/serine-rich splicing factors. RNA. 1:(7):1995;663-680.
25. Gontarek R.R., Derse D. Interactions among SR proteins, an exonic splicing enhancer, and a lentivirus Rev protein regulate alternative splicing. Mol. Cell Biol. 16:(5):1996;2325-2331.
26. Hanon E., Stinchcombe J.C., Saito M., Asquith B.E., Taylor G.P., Tanaka Y., Weber J.N., Griffiths G.M., Bangham C.R. Fratricide among CD8(+) T lymphocytes naturally infected with human T cell lymphotropic virus type I. Immunity. 13:(5):2000;657-664.
27. Jacquenet S., Mereau A., Bilodeau P.S., Damier L., Stoltzfus C.M., Branlant C. A second exon splicing silencer within human immunodeficiency virus type 1 tat exon 2 represses splicing of Tat mRNA and binds protein hnRNP H. J. Biol. Chem. 276:(44):2001;40464-40475.
28. Johnson J.M., Harrod R., Franchini G. Molecular biology and pathogenesis of the human T-cell leukaemia/lymphotropic virus Type-1 (HTLV-1). Int. J. Exp. Pathol. 82:(3):2001;135-147.
29. Johnson J.M., Nicot C., Fullen J., Ciminale V., Casareto L., Mulloy J.C., Jacobson S., Franchini G. Free major histocompatibility complex class I heavy chain is preferentially targeted for degradation by human T-cell leukemia/lymphotropic virus type 1 p12(I) protein. J. Virol. 75:(13):2001;6086-6094.
30. Kim S.J., Ding W., Albrecht B., Green P.L., Lairmore M.D. A conserved calcineurin-binding motif in human T lymphotropic virus type 1 p12I functions to modulate nuclear factor of activated T cell activation. J. Biol. Chem. 278:(18):2003;15550-15557.
31. Kobayashi N., Konishi H., Sabe H., Shigesada K., Noma T., Honjo T., Hatanaka M. Genomic structure of HTLV (human T-cell leukemia virus) detection of defective genome and its amplification in MT-2 cells . EMBO J. 3:(6):1984;1339-1343.
32. Koralnik I.J., Fullen J., Franchini G. The p12I, p13II, and p30II proteins encoded by human T-cell leukemia/lymphotropic virus type I open reading frames I and II are localized in three different cellular compartments. J. Virol. 67:(4):1993;2360-2366.
33. Koralnik I.J., Gessain A., Klotman M.E., Lo Monico A., Berneman Z.N., Franchini G. Protein isoforms encoded by the pX region of human T-cell leukemia/lymphotropic virus type I. Proc. Natl. Acad. Sci. USA. 89:(18):1992;8813-8817.
34. Koralnik I.J., Mulloy J.C., Andresson T., Fullen J., Franchini G. Mapping of the intermolecular association of human T cell leukaemia/ lymphotropic virus type I p12I and the vacuolar H+-ATPase 16 kDa subunit protein. J. Gen. Virol. 76:(Pt. 8):1995;1909-1916.
35. Koyanagi Y., Itoyama Y., Nakamura N., Takamatsu K., Kira J., Iwamasa T., Goto I., Yamamoto N. In vivo infection of human T-cell leukemia virus type I in non-T cells. Virology. 196:(1):1993;25-33.
36. Ladd, A.N., Cooper, T.A., 2002. Finding signals that regulate alternative splicing in the post-genomic era. Genome Biol. 3(11), reviews 0008.
37. Manns A., Hisada M., La Grenade L. Human T-lymphotropic virus type I infection. Lancet. 353:(9168):1999;1951-1958.
38. Mulloy J.C., Crownley R.W., Fullen J., Leonard W.J., Franchini G. The human T-cell leukemia/lymphotropic virus type 1 p12I proteins bind the interleukin-2 receptor beta and gamma c chains and affects their expression on the cell surface. J. Virol. 70:(6):1996;3599-3605.
39. Nagai M., Brennan M.B., Sakai J.A., Mora C.A., Jacobson S. CD8(+) T cells are an in vivo reservoir for human T-cell lymphotropic virus type I. Blood. 98:(6):2001;1858-1861.
40. Nicot C., Mulloy J.C., Ferrari M.G., Johnson J.M., Fu K., Fukumoto R., Trovato R., Fullen J., Leonard W.J., Franchini G. HTLV-1 p12(I) protein enhances STAT5 activation and decreases the interleukin-2 requirement for proliferation of primary human peripheral blood mononuclear cells. Blood. 98:(3):2001;823-829.
41. Pique C., Dokhelar M.C. In vivo production of Rof and Tof proteins of HTLV type 1. evidence from cytotoxic T lymphocytes. AIDS Res. Hum. Retroviruses. 16:(16):2000;1783-1786.
42. Pique C., Ureta-Vidal A., Gessain A., Chancerel B., Gout O., Tamouza R., Agis F., Dokhelar M.C. Evidence for the chronic in vivo production of human T cell leukemia virus type I Rof and Tof proteins from cytotoxic T lymphocytes directed against viral peptides. J. Exp. Med. 191:(3):2000;567-572.
43. Ressler S., Connor L.M., Marriott S.J. Cellular transformation by human T-cell leukemia virus type I. FEMS Microbiol. Lett. 140:(2-3):1996;99-109.
44. Richardson J.H., Edwards A.J., Cruickshank J.K., Rudge P., Dalgleish A.G. In vivo cellular tropism of human T-cell leukemia virus type 1. J. Virol. 64:(11):1990;5682-5687.
45. Seiki M., Hattori S., Hirayama Y., Yoshida M. Human adult T-cell leukemia virus complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA . Proc. Natl. Acad. Sci. USA. 80:(12):1983;3618-3622.
46. Shuh M., Hill S.A., Derse D. Defective and wild-type human T-cell leukemia virus type I proviruses characterization of gene products and trans-interactions between proviruses . Virology. 262:(2):1999;442-451.
47. Stubenrauch F., Laimins L.A. Human papillomavirus life cycle active and latent phases . Sem. Cancer Biol. 9:1999;379-386.
48. Sun Q., Mayeda A., Hampson R.K., Krainer A.R., Rottman F.M. General splicing factor SF2/ASF promotes alternative splicing by binding to an exonic splicing enhancer. Genes Dev. 7:(12B):1993;2598-2608.
49. Tange T.O., Damgaard C.K., Guth S., Valcarcel J., Kjems J. The hnRNP A1 protein regulates HIV-1 tat splicing via a novel intron silencer element. EMBO J. 20:(20):2001;5748-5758.
50. Tange T.O., Kjems J. SF2/ASF binds to a splicing enhancer in the third HIV-1 tat exon and stimulates U2AF binding independently of the RS domain. J. Mol. Biol. 312:(4):2001;649-662.
51. Vande Pol S.B., Howley P.M. Negative regulation of the bovine papillomavirus E5, E6, and E7 oncogenes by the viral E1 and E2 genes. J. Virol. 69:(1):1995;395-402.
52. Yoshida M. HTLV-1 Tax regulation of gene expression and disease . Trends Microbiol. 1:(4):1993;131-135.
53. Yoshida M. Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu. Rev. Immunol. 19:2001;475-496.
54. Zhang W., Nisbet J.W., Albrecht B., Ding W., Kashanchi F., Bartoe J.T., Lairmore M.D. Human T-lymphotropic virus type 1 p30(II) regulates gene transcription by binding CREB binding protein/p300. J. Virol. 75:(20):2001;9885-9895.
55. Zhang W., Nisbet J.W., Bartoe J.T., Ding W., Lairmore M.D. Human T-lymphotropic virus type 1 p30(II) functions as a transcription factor and differentially modulates CREB-responsive promoters. J. Virol. 74:(23):2000;11270-11277.